TY  - GEN
AU  - Overman,M J
AU  - Feng,L
AU  - Pro,B
AU  - McLaughlin,P
AU  - Hess,M
AU  - Samaniego,F
AU  - Younes,A
AU  - Romaguera,J E
AU  - Hagemeister,F B
AU  - Kwak,L
AU  - Cabanillas,F
AU  - Rodriguez,M A
AU  - Fayad,L E
TI  - The addition of rituximab to CHOP chemotherapy improves overall and failure-free survival for follicular grade 3 lymphoma
SN  - 1569-8041
PY  - 2008///0312
KW  - Adult
KW  - Aged
KW  - Aged, 80 and over
KW  - Antibodies, Monoclonal
KW  - administration & dosage
KW  - Antibodies, Monoclonal, Murine-Derived
KW  - Antineoplastic Combined Chemotherapy Protocols
KW  - Cohort Studies
KW  - Cyclophosphamide
KW  - Disease-Free Survival
KW  - Doxorubicin
KW  - Female
KW  - Follow-Up Studies
KW  - Humans
KW  - Lymphoma, Follicular
KW  - drug therapy
KW  - Male
KW  - Middle Aged
KW  - Prednisone
KW  - Proportional Hazards Models
KW  - Rituximab
KW  - Salvage Therapy
KW  - Survival Rate
KW  - Vincristine
N1  - Publication Type: Journal Article
UR  - https://doi.org/10.1093/annonc/mdm511
ER  -